AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (8.6 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Cascade-amplified cuproptosis in hepatocellular carcinoma via a smart hollow mesoporous CuS nanoplatform enabling synergistic phototherapy/chemodynamic therapy/starvation therapy

Wen-Qi Zhu1,3,§, Lin-Song Li1,3,§, Kun Li2,§, Bang-Bang Liu1,3, Dong Cheng1,3, Mei-Xia Zhao1,3 ( )
Henan Key Laboratory of Natural Medicine Innovation and Transformation, Henan University, Kaifeng 475004, China
School of Medicine, Huanghe Science and Technology College, Zhengzhou 450063, China
State Key Laboratory of Antiviral Drugs, Henan University, Kaifeng 475004, China

§ Wen-Qi Zhu, Lin-Song Li, and Kun Li contributed equally to this work.

Show Author Information

Abstract

Emerging copper-mediated lethal mechanisms provide cancer therapies, with current research emphasizing precise copper regulation to enhance its dual role in tumor pathology. Here, we presented a bimetallic nanoplatform, HMCuS/Ru/ICG/GOx@9R-P201Ti (HRIG9R), designed to amplify cuproptosis for hepatocellular carcinoma (HCC) therapy. Upon 808 nm near-infrared (NIR) irradiation, the mild photothermal effect enhanced cytotoxic T-cell differentiation. Concurrently, glucose oxidase (GOx) depletes glucose and generats hydrogen peroxide (H2O2), fueling Ru-mediated chemodynamic therapy (CDT) and reducing Cu2+ to toxic Cu+ to potentiate cuproptosis. This synergistic cascade—integrating starvation, CDT, and adenosine triphosphate (ATP) depletion—reprogrammed the tumor immune microenvironment and induced immunogenic cell death (ICD). These findings highlight the HMCuS/Ru/ICG/GOx@9R-P201Ti nanoplatform as a potent strategy to enhance cuproptosis-based anticancer immunotherapy.

Graphical Abstract

A cascade-reaction nanoplatform (HMCuS/Ru/ICG/GOx@9R-P201Ti, HRIG9R) was developed to potentiate cancer immunotherapy. Guided by the 9R-P201 peptide, the nanoplatform enables precise tumor targeting and efficient delivery of a multifunctional nanocarrier. Intratumoral H2O2 is then catalytically converted into cytotoxic hydroxyl radicals (OH) via Ru/HMCuS bimetallic enzyme-mimetic activity, synergistically integrating starvation therapy with chemodynamic therapy (CDT). This cascade process potentiates cuproptosis induction and amplifies immunogenic cell death (ICD), thereby enhancing antitumor immune responses.

Electronic Supplementary Material

Download File(s)
9207_ESM.pdf (2.4 MB)

References

【1】
【1】
 
 
Nano Research
Article number: 94909207

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhu W-Q, Li L-S, Li K, et al. Cascade-amplified cuproptosis in hepatocellular carcinoma via a smart hollow mesoporous CuS nanoplatform enabling synergistic phototherapy/chemodynamic therapy/starvation therapy. Nano Research, 2027, 20(1): 94909207. https://doi.org/10.26599/NR.2026.94909207

421

Views

58

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 09 July 2026
Revised: 15 September 2026
Accepted: 21 September 2026
Published: 12 November 2026
© The Author(s) 2027. Published by Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0, https://creativecommons.org/licenses/by/4.0/).